Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Genelux Corporation (GNLX)
A side-by-side comparison of Corbus Pharmaceuticals Holdings, Inc. and Genelux Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$5.74HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT
GNLX
Genelux Corporation
$2.56HealthcareDelayed quote: Oct 6, 2026, 3:09 PM EDT
Total return — CRBP vs GNLX
growth of $100 · dividends reinvested · last 4yCRBP +39.3% (+8.6%/yr)GNLX -57.7% (-19.4%/yr)CRBP compounded faster over this window
CRBP GNLX
CRBP vs GNLX: by the numbers
- •GNLX is the larger company ($115M vs $106M market cap).
- •Both run net losses; CRBP's is the smaller (0.00% vs -422412.50% net margin).
Metrics side by side
Valuation
| Metric | CRBP | GNLX |
|---|---|---|
| P/S ratio | N/A | 14341.09 |
| P/B ratio | 1.04 | 7.12 |
Profitability
| Metric | CRBP | GNLX |
|---|---|---|
| Gross margin | 0.00% | -7075.00% |
| Operating margin | 0.00% | -415175.00% |
| Net margin | 0.00% | -422412.50% |
| ROE | -99.67% | -209.73% |
| ROIC | -101.30% | -192.18% |
Growth (annualized)
| Metric | CRBP | GNLX |
|---|---|---|
| Total return CAGR (5Y) | -28.32% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.